NGF blockade did not impair fracture repair in animal models40, but muMab 911 delayed the time to fracture in a sarcoma-induced bone cancer model18, suggesting that the net effect of NGF blockade may be neutral, or to increase bone strength. The gene discussed is NGF; the disease is bone neoplasm.